Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China
  • 10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab
  • 10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...
  • 10/15/2024Dizal's Sunvozertinib Granted BTD in China for Treatment-Naive EGFR Ex...
  • 10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
  • 10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...
  • 10/10/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
  • 10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...
  • 10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...
  • 10/1/2024LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...
  • 10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003
  • 10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201
  • 10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...
  • 10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC
  • 10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...
  • 10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...
  • 10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...
  • 9/27/2024Innovent Submits Marketing Application for Antibody Drug IBI112 for Ps...
  • 9/27/2024Junshi Announces EC Approval of Toripalimab
  • 9/12/2024Innovent's Mazdutide Outperforms Trulicity in Phase III Type 2 Diabete...
  • 9/12/2024GenAssist Dosed the First DMD Clinical Base Editing Drug
  • 9/10/2024China-US Research Team Develops Plant-based Nanoparticles for Brain C...
  • 9/9/2024InnoCare Announces End-of-Phase 2 Meeting with FDA and Agreement to In...
  • 9/9/2024Akeso, Summit's PD-1 Bispecific Beats Merck's Keytruda in China-Only S...
  • 9/4/2024Innovent Granted U.S. Fast Track Designation for Advanced Melanoma Mo...
  • 8/30/2024Virogin Biotech Won Chinese Breakthru Therapy Deisgnation for HCC Drug...
  • 8/30/2024HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...
  • 8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
  • 8/26/2024Chinese and U.S. Scientists Unveil New AI Model to Advance Drug Disco...
  • 8/23/2024China Approves Innovent's Dupert for Advanced Lung Cancer Treatment
  • Page:10/12 Total number of articles:340: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group